✅ Model Answer:
• Diagnosis: Kallmann syndrome (hypogonadotropic hypogonadism + anosmia).
• Evidence: 46,XY, delayed puberty, anosmia, low LH/FSH, low testosterone, renal agenesis (associated with ANOS1/KAL1 mutations).
• Next step: Genetic testing (KAL1/ANOS1, FGFR1, PROKR2, PROK2). MRI brain (absent/hypoplastic olfactory bulbs). Start testosterone replacement (for puberty). For fertility: GnRH pump or gonadotropins (hCG + FSH).

✅ Model Answer:
• Definition: Kallmann syndrome is a form of hypogonadotropic hypogonadism with anosmia (or hyposmia).
• Genes:
- ANOS1 (formerly KAL1): X-linked (most common in males).
- FGFR1: Autosomal dominant.
- PROKR2, PROK2, CHD7, FGF8, WDR11, SOX10: Autosomal recessive or dominant.
• Pathophysiology: Defective migration of GnRH neurons from the olfactory placode to the hypothalamus → GnRH deficiency → low LH/FSH → low sex steroids. Also, olfactory bulb agenesis/hypoplasia → anosmia.
• Prevalence: 1 in 10,000-30,000 (male:female ratio 3-5:1).
• Associated features: Renal agenesis (ANOS1), cleft palate, mirror movements, hearing loss, color blindness, cerebellar ataxia.

✅ Model Answer:
• Classic features:
- Delayed or absent puberty: No testicular enlargement, no pubic hair, no growth spurt.
- Anosmia or hyposmia.
- Micropenis, cryptorchidism (if congenital).
- Eunuchoid proportions.
- Infertility.
- Low bone density.
• Associated features:
- Renal agenesis (unilateral or bilateral – common in ANOS1).
- Midline defects: Cleft palate, cleft lip.
- Mirror movements (bimanual synkinesis) – especially with ANOS1.
- Sensorineural hearing loss.
- Color blindness.
- Cerebellar ataxia.
- Dental agenesis.

✅ Model Answer:
• Karyotype: 46,XY (to rule out Klinefelter).
• Hormonal studies:
- LH/FSH: Low or inappropriately normal.
- Testosterone: Low.
- Estradiol: Low (in females).
- Prolactin: Normal (to rule out hyperprolactinemia).
• Sense of smell: Olfactory testing (University of Pennsylvania Smell Identification Test – UPSIT).
• MRI brain: Absent or hypoplastic olfactory bulbs and sulci (pathognomonic).
• Renal ultrasound: To screen for renal agenesis.
• Genetic testing: ANOS1, FGFR1, PROKR2, PROK2, CHD7, etc.
• Bone age: Delayed.
• Bone density (DEXA).

✅ Model Answer:
• Testosterone replacement (for puberty):
- IM testosterone esters: 50 mg/month initially, increasing to 100-250 mg every 2-4 weeks.
- Transdermal testosterone: 2.5-5 mg/day.
- Duration: Lifelong (unless fertility is desired).
• Fertility (if desired):
- GnRH pump: Intermittent subcutaneous GnRH (pulsatile) to stimulate LH/FSH.
- Gonadotropins: hCG (acts as LH) + FSH (or HMG).
- Spermatogenesis: Usually achieved within 6-24 months.
• Monitoring:
- Testosterone levels.
- Bone density.
- Testicular size (for fertility).
• Psychosocial support.
• Genetic counseling.

✅ Model Answer:
• Infertility: Without treatment, spermatogenesis does not occur.
• Osteoporosis: Due to lack of sex steroids (if untreated).
• Psychosocial: Delayed puberty, body image, self-esteem issues.
• Associated anomalies:
- Renal agenesis: May lead to chronic kidney disease.
- Midline defects: Cleft palate, hearing loss.
- Mirror movements: May affect daily activities.
• Bone health: Fracture risk if untreated.

✅ Model Answer:
• Prognosis:
- Good with testosterone replacement and fertility treatment.
- Puberty: Can be induced successfully.
- Fertility: 70-80% achieve spermatogenesis with GnRH pump or gonadotropins.
- Quality of life: Normal with treatment.
- Life expectancy: Normal.
• Long-term follow-up:
- Monitor testosterone levels.
- Monitor bone density.
- Monitor for associated anomalies.
- Psychosocial support.
- Genetic counseling.

✅ Model Answer:
• Kallmann syndrome:
- Sense of smell: Anosmia or hyposmia.
- Genes: ANOS1 (KAL1), FGFR1, PROKR2, PROK2, CHD7, etc.
- Associated features: Renal agenesis, cleft palate, mirror movements, hearing loss, color blindness.
- MRI: Absent or hypoplastic olfactory bulbs.
• Normosmic hypogonadotropic hypogonadism:
- Sense of smell: Normal.
- Genes: GNRHR, GNRH1, KISS1R, TAC3, TACR3, PROKR2, PROK2, etc.
- Associated features: Usually isolated hypogonadism.
- MRI: Normal olfactory bulbs.
• Both: Low LH/FSH, low testosterone, delayed puberty, micropenis, cryptorchidism.
• Treatment: Same (testosterone replacement, GnRH pump, gonadotropins).